Codon
AUGUST 27, 2024
While reading all the sequences present in a sample, researchers want to find any that are out of place, such as those that belong to a never-before-seen virus. This speedy and well-connected surveillance network grew out of changes made between 2002 and 2006 when USAID and the U.S.
Codon
OCTOBER 13, 2024
Through genetic engineering, researchers have developed Golden Rice which can help address the problem of vitamin A deficiency , cotton that produces its own insecticide , virus-resistant papayas , and more. billion between 1995 and 2006 attempting to eradicate citrus canker alone. Yields were devastated. In 2018, for example, the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
OCTOBER 6, 2021
Data from the early-stage study suggest that an antiviral compound prevents the interaction between two viral proteins (NS3 and NS4B) that play an important role in the replication process of a virus, thereby stopping the ability of the virus to reproduce. Since 2006, Johnson & Johnson has donated more than 1.7
The Pharma Data
JANUARY 8, 2021
It found that nearly 40% of 6,500 HPV vaccine-related posts from 2006 to 2016 amplified a perceived risk. Research must continue to address the perception of vaccine safety where the vaccine is perceived as a greater health threat than the virus or disease it prevents, Luisi added. FRIDAY, Jan. It can cause genital warts and cancer.
The Pharma Data
SEPTEMBER 17, 2020
The new Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in patients who have been exposed to the virus. 3 Knowing a given population’s seroprevalence is important in understanding how to contain the spread of the virus, as well as how to safely ease lockdown restrictions.
The Pharma Data
DECEMBER 16, 2020
National Health and Nutrition Examination Survey from 1988-1994 and 1999-2006. This study found that people with high levels of the chemical have higher death rates from respiratory viruses, such as the flu and pneumonia, suggesting they may also be more vulnerable to COVID-19.
The Pharma Data
APRIL 7, 2021
Approved by the EC in 2006, TYSABRI’s efficacy and safety have been shown through clinical trials and extensive real-world evidence gathered over nearly 15 years. Risk factors that increase the risk of PML are the presence of anti-JC virus antibodies, prior immunosuppressant use and longer TYSABRI treatment duration.
Expert insights. Personalized for you.
97 
Let's personalize your content